Grace Zhou is the founder of Immvira. Immvira has raised $80M in total funding. Latest round: Series C. Based in Shenzhen, China.
Grace Zhou is the founder of ImmVira, a clinical-stage biotechnology company developing oncolytic viral therapies and engineered exosome therapies for cancer treatment. She serves as the Dean of the Shenzhen International Institute for Biomedical Research (SIIBR) in China and is leading ImmVira toward a planned NASDAQ IPO.
Full founder directory · Investor directory · Company funding database · Fundraising library